Skip to main content

Month: May 2023

EVS INVITES ITS SHAREHOLDERS TO A POSTPONED EXTRAORDINARY GENERAL MEETING ON JUNE 5, 2023

Publication on May 19, 2023, before market openingRegulated informationEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS INVITES ITS SHAREHOLDERS TO A POSTPONED EXTRAORDINARY GENERAL MEETING ON JUNE 5, 2023 As already communicated on May 16, 2023, due to the lack of attendance quorum, the Extraordinary General Meeting of EVS Broadcast Equipment SA convened on May 16, 2023 is postponed to June 5, 2023, at 12:00 pm, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). The Board of Directors will propose to this effect to the Shareholders to approve:The grant of the authorization for the Board of Directors to increase the capital within the framework of the authorized capital procedure as per the Belgian Companies and Associations...

Continue reading

Xiao-I Launches Revolutionary Intelligent Document Processing Solution, Catalyzing the Future of Enterprise Document Management

SHANGHAI, China, May 18, 2023 (GLOBE NEWSWIRE) — Xiao-I Corporation (Nasdaq: AIXI) (“Xiao-I” or the “Company”), a leading cognitive artificial intelligence (“AI”) enterprise in China, today announced the launch of its state-of-the-art Intelligent Document Processing (“IDP”) product. This innovative solution is delivered by a smart and efficient platform that streamlines and automates the document management process, empowering businesses towards an era of intelligent operations. In the fast-paced landscape of digital transformation, enterprises frequently grapple with an overwhelming volume of documents, intricate document types, and inefficiency in manual information processing. Xiao-I’s IDP solution addresses these challenges by providing automated document recognition, classification, and key information extraction to...

Continue reading

Ipsen and Marengo Therapeutics announce strategic partnership to advance two precision immuno-oncology candidates from Marengo’s STAR Platform into the clinic

Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation approach Ipsen to pay Marengo $45 million upfront with potential for additional milestone paymentsPARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 01 August, 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Marengo Therapeutics, Inc. today announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic. The collaboration will leverage Marengo’s proprietary R&D expertise of a novel mechanism of T cell activation with Ipsen’s global oncology footprint for clinical development and commercialization. Under the terms of the agreement, Ipsen will make an upfront payment of $45 million, together with potential payments up to a total...

Continue reading

Sylogist to Host Investor Day, Engages LodeRock Advisors

CALGARY, Alberta, May 18, 2023 (GLOBE NEWSWIRE) — Sylogist Ltd. (TSX:SYZ) Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, will host an Investor Day, for institutional investors and analysts, on Tuesday, June 13, 2023, at the St. Regis Hotel in Toronto, Ontario. Presentations will begin at 9:15 a.m. Eastern Time. During the event, Sylogist executive leadership will provide attendees with an update on the Company’s growth opportunities, in-flight initiatives, and business in general. Attendees will also have the opportunity to meet management and participate in a live question-and-answer session. In-person attendees can RSVP for the event by emailing the Company’s investor relations team at ir@sylogist.com. The event will also be available for replay on Sylogist’s...

Continue reading

Purpose Investments Inc. Announces May 2023 Distributions

TORONTO, May 18, 2023 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of May 2023 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all ETFs is May 26, 2023, with the exception of Purpose Bitcoin Yield ETF and Purpose Ether Yield ETF, which will have an ex-distribution date of May 29, 2023, as well as Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund which have an ex-distribution date of May 30, 2023. The ex-distribution date for all closed-end funds is May 30, 2023.Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution FrequencyPurpose Core Dividend Fund – ETF Series PDF $0.10501 05/29/2023 06/07/2023 MonthlyPurpose...

Continue reading

Pacific Health Care Organization, Inc. Reports its First Quarter 2023 Results

Irvine, CA, May 18, 2023 (GLOBE NEWSWIRE) — Quarterly Results The Company reported total revenue of $1,312,643 for the quarter ended March 31, 2023, compared with total revenue of $1,427,383 for the quarter ended March 31, 2022.  The Company reported income from operations of $82,456 for the quarter ended March 31, 2023, compared to income from operations of $262,109 during the quarter ended March 31, 2022.  The Company realized net income of $131,109 or $0.01 per share on a basic and fully diluted basis for the first quarter of 2023, compared to realized net income of $188,535 or $0.01 per share on a basic and fully diluted basis, for the first quarter of 2022. Net cash used in operating activities was $41,382 during the three months ended March 31, 2023, compared to net cash provided by operating activities of $459,370 during...

Continue reading

Meritage Homes Announces Quarterly Cash Dividend

SCOTTSDALE, Ariz., May 18, 2023 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), the fifth-largest homebuilder in the U.S., today announced that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.27 per share. This dividend is payable on June 30, 2023 to shareholders of record as of the close of trading on June 15, 2023. About Meritage Homes Corporation Meritage Homes is the fifth-largest public homebuilder in the United States, based on homes closed in 2022. The Company offers affordable, energy-efficient entry-level and first move-up homes. Operations span across Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina and Tennessee. Meritage Homes has delivered over 165,000 homes in its 37-year history, and has a reputation for its distinctive style,...

Continue reading

Qifu Technology Announces First Quarter 2023 Unaudited Financial Results and Changes in Dividend Policy

SHANGHAI, China, May 18, 2023 (GLOBE NEWSWIRE) — Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2023, and changes in dividend policy. First Quarter 2023 Business HighlightsAs of March 31, 2023, our platform has connected 150 financial institutional partners and 214.5 million consumers*1 with potential credit needs, cumulatively, an increase of 11.2% from 192.9 million a year ago. Cumulative users with approved credit lines*2 were 46.0 million as of March 31, 2023, an increase of 15.6% from 39.8 million as of March 31, 2022. Cumulative borrowers with successful drawdown, including repeat borrowers was 27.7 million as of March 31, 2023, an increase of 10.8% from 25.0...

Continue reading

Atlas Signs Definitive Agreement to Acquire an Additional Pharmacy and Provides Update on Expanding its Global Cannabis Footprint and Progressing Its International Value Chain Strategy

Atlas Global Brands signs definitive agreement to acquire an additional Israeli pharmacy The additional medical cannabis pharmacy enhances Atlas’ premium positioning in the Israeli market with its modern design, located in central Israel The completion of this acquisition will add another Israel-based pharmacy, licensed to sell medical cannabis, strengthening Atlas’ geographical coverage in Israel Inclusive of the previously announced signed letters of intent and definitive agreements, upon closing of these transactions, Atlas will own a majority interest in six pharmacies along with a trading house distribution centre in IsraelCHATHAM, ONTARIO and TEL-AVIV, ISRAEL, May 18, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc. (“Atlas Global”, “Atlas” or the “Company”) (CSE: ATL), a cannabis company with expertise across the value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.